Back to previous step
RWC Medical is pleased to present an outstanding opportunity to acquire one of Perth's largest and most sought-after pharmaceutical manufacturing facilities. Located in the highly desirable Balcatta industrial precinct, just 10km north of Perth's CBD, this premium asset offers exceptional connectivity, long-term investment security, and unparalleled tenant strength.
Investment Highlights:
• Secure 15-Year Triple Net Lease: Commencing 1 June 2025, with options extending to 2060, providing long-term income certainty.
• Established Pharmaceutical Tenant: Leased to Evaris Pharma (formerly Perrigo Australia), a renowned pharmaceutical company with a 40-year legacy.
• Substantial Income Stream: Generates a net income of $1,511,270 per annum, all outgoings fully covered by the tenant.
• Rare TGA & GMP Certifications: One of Australia's few industrial sites with Therapeutic Goods Administration (TGA) and Good Manufacturing Practice (GMP) approvals, making it a highly valuable and hard-to-replicate asset.
• Prime Landholding: Spanning 8,594sqm, the site offers significant long-term capital growth potential in a land-constrained market.
• Strategic Location: Easy access to major arterial routes including the Mitchell Freeway, Reid Highway, and Wanneroo Road, ensuring excellent distribution capabilities.
• Premium Industrial Precinct: Balcatta remains a tightly held market with strong demand from high-quality industrial and commercial occupiers.
• Triple Net Lease (NNN): The tenant is responsible for all outgoings, including property taxes, insurance, maintenance, and capital expenditures, ensuring minimal ownership costs.
Expressions of Interest Close:
Thursday 24th April 2025, 4:00 PM AEST
For further details or to access the data room, please contact the exclusive sales agents:
Franz Stapelberg - Director | +61 430 655 676 | [email protected]
Nicolas Milner - Sales Agent | +61 416 433 217 | [email protected]
Remember to mention you found this property on CommercialReady
RWC Medical is pleased to present an outstanding opportunity to acquire one of Perth's largest and most sought-after pharmaceutical manufacturing facilities. Located in the highly desirable Balcatta industrial precinct, just 10km north of Perth's CBD, this premium asset offers exceptional connectivity, long-term investment security, and unparalleled tenant strength.
Investment Highlights:
• Secure 15-Year Triple Net Lease: Commencing 1 June 2025, with options extending to 2060, providing long-term income certainty.
• Established Pharmaceutical Tenant: Leased to Evaris Pharma (formerly Perrigo Australia), a renowned pharmaceutical company with a 40-year legacy.
• Substantial Income Stream: Generates a net income of $1,511,270 per annum, all outgoings fully covered by the tenant.
• Rare TGA & GMP Certifications: One of Australia's few industrial sites with Therapeutic Goods Administration (TGA) and Good Manufacturing Practice (GMP) approvals, making it a highly valuable and hard-to-replicate asset.
• Prime Landholding: Spanning 8,594sqm, the site offers significant long-term capital growth potential in a land-constrained market.
• Strategic Location: Easy access to major arterial routes including the Mitchell Freeway, Reid Highway, and Wanneroo Road, ensuring excellent distribution capabilities.
• Premium Industrial Precinct: Balcatta remains a tightly held market with strong demand from high-quality industrial and commercial occupiers.
• Triple Net Lease (NNN): The tenant is responsible for all outgoings, including property taxes, insurance, maintenance, and capital expenditures, ensuring minimal ownership costs.
Expressions of Interest Close:
Thursday 24th April 2025, 4:00 PM AEST
For further details or to access the data room, please contact the exclusive sales agents:
Franz Stapelberg - Director | +61 430 655 676 | [email protected]
Nicolas Milner - Sales Agent | +61 416 433 217 | [email protected]
Remember to mention you found this property on CommercialReady
25 Delawney Street, Balcatta, WA, 6021
Secure/no obligation
Step 1
Loan Variables
Adjust the inputs to explore your indicative finance options.
Estimated Purchase Price:
What you intend to pay for the property
Your Contribution:
The amount you’re investing
Min: 0% - Max: 90% of purchase price.
LVR:
Loan to Value Ratio
Min: 10% - Max: 100% of purchase price.
Loan Analysis
Yield Calculator
Yield Calculator
Step 1
Loan Variables
Adjust the inputs to explore your indicative finance options.
Estimated Purchase Price:
What you intend to pay for the property
Your Contribution:
The amount you’re investing
Min: 0% - Max: 90% of purchase price.
LVR:
Loan to Value Ratio
Min: 10% - Max: 100% of purchase price.
Loan Analysis
Full report
Please see your Loan Analysis below. The report has been emailed to you, as well as DIG Capital Advisory and the Listing Agent to follow up if needed.
Loan Analysis
